About
Services
Industries
Press & insights
resources
contact
We're on a mission to help companies of all sizes identify the best locations, secure incentives, obtain development approvals and optimize energy strategies through Location Economics®.
BLS & Co. serves as location and incentives advisor to Roche, Swiss multinational healthcare leader, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012, supporting over $2.7 billion in announced investments.
BLS & Co. serves aslocation and incentives advisor to Roche, Swiss multinational healthcare company, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012 with four major projects announced as of 2026:
BLS & Co. utilizes an assortment of services – a process we call Location Economics® – to advise clients on location decisions. Discover our variety of offerings to help you navigate the complex decision making processes that occur when searching for a new location for your organization.
BLS & Co. specializes in a variety of industries and our dedicated team is compromised of experts in nearly all major categories.
At BLS & Co., we have executed wide variety of projects for our clients, which includes facilities such as headquarters, warehouses, and data centers.
Stay up to date with BLS & Co. by exploring our latest news and musings on the world of site selection and more.
We're proud to provide a few key resources to help get you started on your site selection journey.
Search our North American database for the right location for your company's HQ, R&D Facilities, and more.
Browse our regional resource guide for site selection in the U.S.
If your organization is confronting complex and sensitive location decisions, please reach out to schedule a confidential conversation.
Interested in a career opportunity with BLS & Co.? Click below to learn more about our growing team and view all current openings.
In an article in fDi Intelligence, BLS & Co. managing director Tracey Hyatt Bosman discusses the projected pace of cleantech projects under the new administration. Read more in the article below:
A holding pattern
Sean Riddick, a senior advisor at cleantech advisory Apricum, said firms have a “wait-and-see perspective on project development", warning many will be “in a holding pattern” until the Trump administration’s policies become clearer.
As the industry regroups for Trump 2.0, OCO Global CEO Gareth Hagan is among those to warn the new administration’s policies won’t lead to a large pullback from cleantech investors. “These are becoming structurally important industries globally. The idea that [Mr Trump is] going to give the whole industry a red card? It doesn’t work that way,” he said.
However the Biden-era fervour of clean project announcements, fuelled by the race for incentives, may be a thing of the past. “We’re going to continue seeing project activity, but I would expect it to progress at a more organic pace,” said Tracey Hyatt Bosman, managing director of site selector BLS & Co.
Read more here.
Tracey Hyatt Bosman develops and executes incentives and location selection strategies for BLS & Co.'s corporate and institutional clients. She is a certified economic developer with twenty years of professional experience across a wide range of sectors, including data centers, manufacturing, headquarters, back office and contact center operations, and logistics.
We're on a mission to help companies of all sizes identify the best locations, secure incentives, obtain development approvals and optimize energy strategies through Location Economics®.
BLS & Co. serves as location and incentives advisor to Roche, Swiss multinational healthcare leader, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012, supporting over $2.7 billion in announced investments.
BLS & Co. serves aslocation and incentives advisor to Roche, Swiss multinational healthcare company, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012 with four major projects announced as of 2026:
BLS & Co. utilizes an assortment of services – a process we call Location Economics® – to advise clients on location decisions. Discover our variety of offerings to help you navigate the complex decision making processes that occur when searching for a new location for your organization.
BLS & Co. specializes in a variety of industries and our dedicated team is compromised of experts in nearly all major categories.
At BLS & Co., we have executed wide variety of projects for our clients, which includes facilities such as headquarters, warehouses, and data centers.
Stay up to date with BLS & Co. by exploring our latest news and musings on the world of site selection and more.
We're proud to provide a few key resources to help get you started on your site selection journey.
Search our North American database for the right location for your company's HQ, R&D Facilities, and more.
Browse our regional resource guide for site selection in the U.S.
If your organization is confronting complex and sensitive location decisions, please reach out to schedule a confidential conversation.
Interested in a career opportunity with BLS & Co.? Click below to learn more about our growing team and view all current openings.
